Author: Nicholas Caito

Dr. Frieden Mentioned

November 4th, 2019 – Research by Dr. Carl Frieden appeared on the Alzforum site in the article “Can an ApoE Mutation Halt Alzheimer’s Disease?”

One of Dr. Frieden’s previous publications was also cited by the article.

Click here to view the article on the Alzform site.

To view Dr. Frieden’s publication mentioned in the article, you can click here to view it on the NIH site.

A novel chlorophyll protein complex in the repair cycle of photosystem II.

Weisz D.A., Johnson V.M., Niedzwiedzki D.M., Shinn M.K., Liu H., Klitzke C.F., Gross M.L., Blankenship R.E., Lohman T.M., & Pakrasi H.B. (2019). “A novel chlorophyll protein complex in the repair cycle of photosystem II.” Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21907-21913. doi: 10.1073/pnas.1909644116. Epub 2019 Oct 8. (Abstract)

The telomere-binding protein Rif2 and ATP-bound Rad50 have opposing roles in the activation of yeast Tel1ATM kinase.

Hailemariam S., De Bona P., Galletto R., Hohl M., Petrini J.H., & Burgers P.M. (2019). “The telomere-binding protein Rif2 and ATP-bound Rad50 have opposing roles in the activation of yeast Tel1ATM kinase.” J Biol Chem. 2019 Oct 22. pii: jbc.RA119.011077. doi: 10.1074/jbc.RA119.011077. [Epub ahead of print] (Abstract)

2019 Elliot Elson Fellowship Seminar

On September 20th, 2019, the department held a special seminar to recognize the recipient of the 2018 Elliot Elson Fellowship. Ms. Sarah Clippinger shared her research on “Assembly and Binding of E. coli RecOR Proteins to SSB C-terminal tails”. For more information on Sarah, please click here.

You can click here to view photos from the event.

Inhibitors of pro-HGF activation overcome resistance to anti-EGFR therapy

September 16th, 2019 – Jim Janetka, PhD, Associate Professor of Biochemistry and Molecular Biophysics, and Co-Founder of ProteXase Therapeutics, Inc., along with Lidija Klampfer, PhD, Co-Founder and Chief Scientific Officer of ProteXase Therapeutics, Inc., received a one-year SBIR grant award from the National Cancer Institute for their research entitled “Inhibitors of pro-HGF activation overcome resistance to anti-EGFR therapy”.

2019 MilliporeSigma Fellowship Seminar

On July 19th, 2019, the department held a special seminar to recognize the recipient of the 2019 MilliporeSigma Fellowship. Mr. Sukrit Singh shared his research on “Allostery in cellular signaling: Capturing biological switches in action”. For more information on Sukrit Singh, please click here.

You can click here to view photos from the event.